Analyst opinions on Zhangzhou Pientzehuang Pharmaceutical sh...
Analyst opinions on Zhangzhou Pientzehuang Pharmaceutical show dim prospects with reduced earnings and revenue forecasts. Despite unchanged price targets, uncertainty looms over future performance.
Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment